Content about Herb Kohl

December 14, 2011

NACDS aims to set record straight regarding PBM testimony at Senate hearing

The National Association of Chain Drug Stores on Wednesday challenged some of Express Scripts' and Medco's testimony during last week's hearing before the Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, most notably that PBMs are subject to state regulation in all states and that as a PBM the two companies have no influence on the design of prescription drug benefits.

December 1, 2011

Senators look into Pfizer-PBM deal for Lipitor

Pfizer's efforts to protect the sales of its blockbuster cholesterol drug Lipitor have attracted scrutiny from members of Congress, according to published reports.

October 21, 2011

Senators urge congressional super committee to support 'pay-for-delay' ban

Two senators are trying to get the Joint Select Committee on Deficit Reduction to take up a bill that would ban so-called "pay-for-delay" patent settlements between brand and generic drug companies, according to published reports.

September 26, 2010

Senate, courts debate legality of patent settlement deals

For all its successes, the generic drug industry has had a lot to worry about...

September 9, 2010

Sorry, FTC: 'Pay-for-delay' isn't going away

This week’s decision by the U.S. Second Circuit Court of Appeals could make political efforts...